Shijiazhuang Yiling Pharmaceutical Co., Ltd. (SHE:002603)
China · Delayed Price · Currency is CNY 15.48
+0.24 (1.57%)
Oct 30, 2026, 3:04 PM CST
SHE:002603 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 7,932 | 7,831 | 6,513 | 10,318 | 12,533 | 10,117 |
Revenue Growth | 31.86% | 20.24% | -36.88% | -17.67% | 23.88% | 15.19% |
Gross Profit Gross Profit Growth | 5,227 | 4,956 | 3,027 | 5,884 | 7,976 | 6,417 |
Operating Income Operating Income Growth | 1,679 | 1,605 | -837.02 | 1,613 | 2,853 | 1,519 |
Net Income Net Income Growth | 1,382 | 1,286 | -724.52 | 1,352 | 2,363 | 1,344 |
Earnings Per Share EPS Growth | 0.83 | 0.77 | -0.43 | 0.81 | 1.41 | 0.80 |
EPS Growth | - | - | - | -42.76% | 75.81% | 10.27% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
China China Growth | 7,528 | 6,218 | 10,079 | 12,070 | 9,760 |
Overseas Overseas Growth | 302.37 | 294.91 | 239.34 | 462.58 | 356.64 |
Total Total Growth | 7,831 | 6,513 | 10,318 | 12,533 | 10,117 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 2,518 | 1,869 | 853.03 | 1,146 | 2,423 | 1,051 |
Total Debt Total Debt Growth | 21.07 | 25.74 | 26.45 | 1,419 | 871.45 | 1,229 |
Net Cash (Debt) Net Cash Growth | 2,497 | 1,844 | 826.58 | -272.6 | 1,551 | -178.37 |
Net Cash Growth | 30.43% | 123.04% | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | 1.49 | 1.10 | 0.49 | -0.16 | 0.93 | -0.11 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 2,107 | 1,777 | 611.01 | 155.46 | 3,488 | 528.69 |
Capital Expenditures CapEx Growth | -211.69 | -245.62 | -290.39 | -310.83 | -213.98 | -673.56 |
Free Cash Flow Free Cash Flow Growth | 1,895 | 1,531 | 320.62 | -155.38 | 3,274 | -144.87 |
Free Cash Flow Growth | 41.63% | 377.48% | - | - | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 65.91% | 63.29% | 46.47% | 57.03% | 63.64% | 63.43% |
Operating Margin | 21.16% | 20.50% | -12.85% | 15.63% | 22.77% | 15.01% |
Pretax Margin | 21.93% | 20.33% | -12.29% | 16.32% | 22.19% | 15.36% |
Profit Margin | 17.42% | 16.43% | -11.13% | 13.11% | 18.85% | 13.28% |
FCF Margin | 23.90% | 19.55% | 4.92% | -1.51% | 26.12% | -1.43% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.800 | 0.800 | - | 0.300 | 0.500 | 0.300 |
Dividend Per Share Growth | 0% | - | - | -40.00% | 66.67% | -58.00% |
Dividend Yield | 5.17% | 4.69% | - | 1.30% | 1.67% | 1.53% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 18.71 | 22.17 | - | 28.50 | 21.19 | 24.37 |
Forward PE | 17.20 | 21.57 | 18.07 | 16.45 | 27.48 | 15.62 |
P/FCF Ratio | 13.65 | 18.63 | 83.43 | - | 15.29 | - |
PS Ratio | 3.26 | 3.64 | 4.11 | 3.74 | 3.99 | 3.24 |